Main Menu

Odonate Therapeutics, Inc.


Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Odonate Therapeutics, Inc. ("Odonate") on behalf of stockholders.  A class action complaint has been filed against Odonate, which alleges that defendants made materially false and misleading statements regarding Odonate's business, operational, and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) tesetaxel was not as safe or well-tolerated as Odonate had led investors to believe; (ii) thus, tesetaxel's commercial viability as a cancer treatment was overstated; and (iii) accordingly, Odonate's public statements were materially false and misleading at all relevant times. 

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 07/17/2024

* Indicates a required field.

Back to Page